Menu
19/10/2011
Ruling Could Stop Euro Stem Cell Research – Scientists
Stem-cell scientists in Europe are reeling from a ruling on Wednesday banning patents on stem cells obtained through the destruction of human embryos.
The decision by the European Court of Justice means that no European patents will be given for research based on stem cells extracted from anything capable of developing into a human being.
According to the complex ruling, any process that involves removal of a stem cell from a human embryo at the "blastocyst" (five days after fertilization) stage that leads to the destruction of the embryo cannot be patented.
However, the ruling adds that the use of human embryos for developing therapeutic or diagnostic inventions for humans is patentable, even if their use for scientific research is not.
The decision is the culmination of a long-running legal battle, which came down to the European Patent Convention of 1973, which banned patents that were "contrary to public order and morality".
Researchers are furious with the ruling, the result of a challenge in 1999 by environmental lobby group Greenpeace to a patent on neural precursor cells obtained two years earlier by Oliver Brüstle, now at the University of Bonn in Germany.
A statement today from the environmental campaign group said: "Greenpeace is against the patenting of human life. Greenpeace is not anti-stem cell research. Europe has outlawed patents on uses of human embryos for industrial or commercial purpose and this case aims to clarify the law. This decision of the court clearly set clear limits to the commercialization of human life and we welcome it."
According to eurostemcell.org, scientists are concerned that the verdict, which is legally binding for all EU states, will drive development of stem cell therapies outside Europe.
Professor Brüstle said: "With this unfortunate decision, the fruits of years of translational research by European scientists will be wiped away and left to the non-European countries.
"European researchers may conduct basic research, which is then implemented elsewhere in medical procedures, which will eventually be re-imported to Europe. How do I explain that to the young scientists in my lab?”
Professor Austin Smith of the Wellcome Trust Centre for Stem Cell Research at the University of Cambridge, said decision by the Court leaves scientists in a "ridiculous position".
"We are funded to do research for the public good, yet prevented from taking our discoveries to the market place where they could be developed into new medicines. One consequence is that the benefits of our research will be reaped in America and Asia”
Despite his disappointment about the Court’s verdict, Professor Bruestle said he was optimistic that stem cell technology would continue to progress on an international level.
(DW/CD)
The decision by the European Court of Justice means that no European patents will be given for research based on stem cells extracted from anything capable of developing into a human being.
According to the complex ruling, any process that involves removal of a stem cell from a human embryo at the "blastocyst" (five days after fertilization) stage that leads to the destruction of the embryo cannot be patented.
However, the ruling adds that the use of human embryos for developing therapeutic or diagnostic inventions for humans is patentable, even if their use for scientific research is not.
The decision is the culmination of a long-running legal battle, which came down to the European Patent Convention of 1973, which banned patents that were "contrary to public order and morality".
Researchers are furious with the ruling, the result of a challenge in 1999 by environmental lobby group Greenpeace to a patent on neural precursor cells obtained two years earlier by Oliver Brüstle, now at the University of Bonn in Germany.
A statement today from the environmental campaign group said: "Greenpeace is against the patenting of human life. Greenpeace is not anti-stem cell research. Europe has outlawed patents on uses of human embryos for industrial or commercial purpose and this case aims to clarify the law. This decision of the court clearly set clear limits to the commercialization of human life and we welcome it."
According to eurostemcell.org, scientists are concerned that the verdict, which is legally binding for all EU states, will drive development of stem cell therapies outside Europe.
Professor Brüstle said: "With this unfortunate decision, the fruits of years of translational research by European scientists will be wiped away and left to the non-European countries.
"European researchers may conduct basic research, which is then implemented elsewhere in medical procedures, which will eventually be re-imported to Europe. How do I explain that to the young scientists in my lab?”
Professor Austin Smith of the Wellcome Trust Centre for Stem Cell Research at the University of Cambridge, said decision by the Court leaves scientists in a "ridiculous position".
"We are funded to do research for the public good, yet prevented from taking our discoveries to the market place where they could be developed into new medicines. One consequence is that the benefits of our research will be reaped in America and Asia”
Despite his disappointment about the Court’s verdict, Professor Bruestle said he was optimistic that stem cell technology would continue to progress on an international level.
(DW/CD)
Related UK National News Stories
Click here for the latest headlines.
02 December 2005
Government pledges cash for stem cell research
The government has announced that an extra £50 million will be made available for UK stem cell research over the next two years. The announcement followed the publication of the UK Stem Cell Initiative report, which has recommended that that the government should invest at least £350 million in the research over the next decade.
Government pledges cash for stem cell research
The government has announced that an extra £50 million will be made available for UK stem cell research over the next two years. The announcement followed the publication of the UK Stem Cell Initiative report, which has recommended that that the government should invest at least £350 million in the research over the next decade.
19 May 2008
MP's To Vote On Human-Animal Embryo Research
The Commons is to vote on controversial plans for research to be carried out using human-animal embryos today which could mark a turning point in medicine. Prime Minister Gordon Brown is backing the measures saying it could save "millions of lives".
MP's To Vote On Human-Animal Embryo Research
The Commons is to vote on controversial plans for research to be carried out using human-animal embryos today which could mark a turning point in medicine. Prime Minister Gordon Brown is backing the measures saying it could save "millions of lives".
19 May 2004
World's first stem cell bank opens in London
A world's first bank for embryonic stem cells – research into which could lead to improved treatment for currently incurable diseases – has been opened by Health Minister Lord Warner in London today.
World's first stem cell bank opens in London
A world's first bank for embryonic stem cells – research into which could lead to improved treatment for currently incurable diseases – has been opened by Health Minister Lord Warner in London today.
09 July 2010
Skin Cancer Linked To Warts Infection
Suffering the virus that causes warts and verrucas can increase the risk of certain cancers. An international team of researchers has found that people with several types of the virus - human papillomaviruses (HPVs) - were more than one and a half times as likely to develop certain skin cancers compared to people with no HPVs.
Skin Cancer Linked To Warts Infection
Suffering the virus that causes warts and verrucas can increase the risk of certain cancers. An international team of researchers has found that people with several types of the virus - human papillomaviruses (HPVs) - were more than one and a half times as likely to develop certain skin cancers compared to people with no HPVs.
12 October 2015
£200m Polar Research Ship To Be Built
The preferred bidder to construct a £200m state-of-the-art polar research ship has been named. Cammell Laird in Birkenhead has been selected as the preferred bidder for the project which will help the UK remain at the forefront of climate and ocean research.
£200m Polar Research Ship To Be Built
The preferred bidder to construct a £200m state-of-the-art polar research ship has been named. Cammell Laird in Birkenhead has been selected as the preferred bidder for the project which will help the UK remain at the forefront of climate and ocean research.
-
Northern Ireland WeatherToday:After a dry start this morning rain will spread from the northwest across all parts. This afternoon will be dull with some patchy rain and drizzle. Becoming much milder through the afternoon. Maximum temperature 11 °C.Tonight:A cloudy evening and night with a little light rain or drizzle, perhaps some clear periods developing along the east coast. A very mild night everywhere. Minimum temperature 10 °C.
